Rockefeller Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.9K Sell
1,730
-1,192
-41% -$48.1K ﹤0.01% 3108
2026
Q1
$96.8K Buy
2,922
+578
+25% +$18.8K ﹤0.01% 2893
2025
Q4
$76.7K Sell
2,344
-3,856
-62% -$94.8K ﹤0.01% 2850
2025
Q3
$111K Buy
+6,200
New +$90K ﹤0.01% 2539
2021
Q4
Sell
-518
Closed -$8K 3762
2021
Q3
$8K Hold
518
﹤0.01% 2972
2021
Q2
$11K Buy
+518
New +$10.5K ﹤0.01% 2730

Other funds holding AXGN

Rockefeller Capital Management's AXGN Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Axogen (AXGN) stake by 41% in Q2 2026, selling an estimated $48.1K and leaving 1,730 shares worth $79.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3108.

Rockefeller Capital Management first reported a position in AXGN in Q2 2021 and has held it in 6 quarters since. The position peaked at $111K in Q3 2025. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Rockefeller Capital Management held 1,730 shares of Axogen worth $79.9K as of Q2 2026.
  • Rockefeller Capital Management sold 1,192 Axogen shares in Q2 2026, an estimated $48.1K.
  • Axogen made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3108 holding.
  • Rockefeller Capital Management first reported a position in Axogen in Q2 2021 and has held it in 6 quarters since.
  • Rockefeller Capital Management's Axogen position peaked at $111K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.